A carregar...
A robust in vivo model for B cell precursor acute lymphoblastic leukemia
B cell precursor acute lymphoblastic leukemia (BCP ALL) is the most common malignancy in children. While treatments have improved remarkably over the past four decades, resistant disease and late effects that result from cytotoxic chemotherapy remain serious problems for individuals with BCP ALL. Im...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588242/ https://ncbi.nlm.nih.gov/pubmed/26301807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI83799 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|